This grant funds research to advance understanding of STXBP1 biology and develop new therapies for STXBP1-related disorders.
Curative Therapies Grant supports scientists worldwide researching curative and disease-modifying therapies for Fragile X syndrome, with the goal of bringing practical treatments into medical practice.
The Investor-Initiated Research Grants from Beyond Batten Disease Foundation fund global research to advance understanding and treatment of juvenile Batten (CLN3) disease.
FRAXA Clinical Trial Grant supports scientists studying people with Fragile X syndrome, prioritizing trials of disease-modifying treatments to advance practical therapies and ultimately a cure.
Huntington's Disease Foundation Research Grants support independent researchers generating preliminary data on disease mechanisms and therapeutics to advance research and secure long-term funding.